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Abstract: Diffusion tensor imaging (DTI) is a sophisticated MRI-based neuroimaging technique 
that enables in vivo quantiﬁ  cation of differences in molecular diffusion at the cellular level. 
Owing to the highly directional architecture of white matter (WM), DTI is providing important 
clues of the structure and geometric organization of this neural compartment. Since DTI can 
detect changes even in the case of radiologically “normal” appearing WM, researchers are using 
the technique for the study of WM integrity at the initial stages of the most common neurode-
generative disorders. Along with a well characterized cortical pathology (neuritic plaques and 
intracellular neuroﬁ  brillary tangles), WM changes have been also demonstrated in Alzheimer’s 
disease (AD). However, these changes had been for years found nonliable in the onset and 
progress of AD, basically due to lack of incriminatory evidence. The use of novel tools such as 
DTI has enabled the anatomical distribution of WM microstructural damage in the prodromal 
stages of AD to be gauged and determined, granting a long-delayed protagonic role to WM in 
the natural history of this highly prevalent neurodegenerative condition.
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The study of molecular diffusion by means of magnetic resonance imaging (MRI) 
has had a great impact in modern neuroscience. An MRI-based technique called dif-
fusion weighted imaging (DWI) is perhaps one of the best examples of translational 
research from the basic sciences to the clinical arena – exploiting changes in cellular 
water diffusion properties and providing key information on the actual physiologi-
cal state of brain tissue beyond the purely “anatomical” data. DWI enables a robust 
visualization of abnormalities within minutes of onset of cerebral ischemia (Moseley 
et al 1990; Hossmann and Hoehn-Berlage 1995; Lutsep et al 1997; Yoneda et al 1999; 
Lansberg et al 2000), as well as white matter (WM) microstructural changes in several 
neurological conditions (Higano et al 2001), including the dementia syndrome caused 
by Alzheimer’s disease (Hanyu et al 1998, 1999; Sandson et al 1999; Bozzao et al 
2001; Kantarci et al 2001).
When physical barriers are absent, diffusion is isotropic, ie, equal in every direc-
tion. However, the intrinsic peculiarities of biological microenvironments work as 
constrictors of free water diffusion, obligating molecules to ﬂ  ow in a directional or 
anisotropic fashion. Despite its well deserved position as the standard imaging aid 
for the diagnosis and management of acute stroke (Neumann-Haefelin et al 2000; 
Lansberg et al 2001), the information obtained from conventional DWI is limited to one 
dimension, based only on intensity values. To overcome this limitation, investigators Neuropsychiatric Disease and Treatment 2008:4(4) 738
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engineered a sophisticated MRI modality called diffusion 
tensor imaging (DTI; Le Bihan et al 2001). DTI quantiﬁ  es 
molecular motion at the voxel level by means of a tensor, a 
mathematical concept that allows for complete tridimensional 
description of both the direction and the average magnitude 
of water diffusion (Basser et al 1994a, b; Basser 1995).
The structure of WM consists mainly of highly organized, 
directionally insulated tracts formed by myelin-covered 
axons. Hence, diffusion anisotropy is more likely to be higher 
in WM than in other tissues, eg, gray matter (GM). DTI mea-
sures of WM anisotropy such as fractional anisotropy (FA; 
Basser and Pierpaoli 1996) are currently regarded as markers 
of the integrity of neural axons (Beaulieu 2002), positioning 
the technique as a reliable indicator of defects in geometric 
organization and ﬁ  ber architecture in the context of disease. 
DTI has the advantage of examining the microstructural 
integrity of even radiologically “normal” appearing WM, 
enabling assessment of the status of WM at the initial stages 
of the most common neurodegenerative disorders.
Use of DTI to address 
the “dementia problem”
Alzheimer’s disease (AD) is pathologically deﬁ  ned by the 
presence of neuritic plaques, intracellular neuroﬁ  brillary 
tangles, and a greater loss of cortical neurons than in same-
age, non-demented persons. Although they are most common 
in vascular dementia, independent white matter changes 
(WMC) have also been found in AD to a greater extent than 
in age-matched controls (Brun and Englund 1986; Englund 
1998; Kalaria 2000, 2002; Bronge et al 2002). However, the 
role of WMC in the pathogenesis, disease progression, and 
cognitive features of AD remained unsolved.
Mild cognitive impairment (MCI) is usually deﬁ  ned 
as a slight impairment in cognitive function – memory, in 
the case of amnestic MCI – but lacking enough criteria to 
be considered full dementia. MCI has become a common 
diagnosis in later life and is associated with a high risk of 
developing AD, with yearly conversion rates estimated at 
10%–15% (Petersen et al 2001). In vivo anatomical markers 
determined by quantitative MRI methods are being suc-
cessfully used to differentiate patients with MCI and AD, 
respectively, from normal controls, and highly predictive 
indices of conversion (from MCI to AD) have been gener-
ated (deToledo-Morrell et al 2000, 2004; Killiany et al 2000, 
2002; Dickerson et al 2001).
Although mesial temporal cortical structures involved 
in memory function, such as the hippocampus and entorhinal 
cortex, have been traditionally under the scope of AD research 
(Jack et al 1992, 1997; Convit et al 1997; deToledo-Morrell 
et al 1997, 2000, 2004; Bobinski et al 1999; Killiany et al 
2000, 2002; Xu et al 2000; Callen et al 2001; Dickerson et al 
2001; Du et al 2001), DTI now is guiding scientists in their 
observations of the WM microstructural changes associated 
with aging and aging-related cognitive decline in the living 
brain. In AD in particular, the study of anisotropy changes 
has been focused on the prodromal and initial stages of the 
disease.
The localization of DTI-derived WM changes has been 
accomplished mostly by three methods: a) Selecting a 
region of interest (ROI), usually prescribed manually and 
from which anisotropy values are measured for statistical 
comparisons. b) Selecting a tract of interest from which the 
main eigenvector of diffusion, parallel to the major axis of 
the ﬁ  ber bundle, is calculated. This method is called tractog-
raphy and uses color codes and predetermined anatomical 
seeds (Conturo et al 1999; Pajevic and Pierpaoli 1999), to 
virtually dissect a complete WM tract from its origin to its 
termination in the brain (Virta et al 1999; Poupon et al 2000). 
c) More recently, fully automated whole-brain algorithms 
have been adopted to register individual anisotropy maps 
into standard space, and compute their changes by voxel-
based statistics.
Using the ROI approach, several studies have looked at 
the WM of multiple brain lobes and some functionally rel-
evant structures such as the superior longitudinal fasciculus, 
the cingulum bundle, and the corpus callosum. In summary, 
the majority of regional changes found in DTI indices of WM 
integrity are located posteriorly in the brains of MCI and 
AD subjects (Rose et al 2000; Bozzali et al 2002; Takahashi 
et al 2002; Yoshiura 2002; Fellgiebel et al 2004, 2007; Head 
et al 2004; Duan et al 2006; Naggara et al 2006; Huang and 
Auchus 2007; Huang et al 2007; Sydykova et al 2007). In 
contrast, effects of normal aging were found to be of greater 
magnitude in the WM of the frontal lobe and the anterior cor-
pus callosum than in the WM of temporal, parietal, occipital, 
and posterior callosum regions (Head et al 2004).
Medina et al (2006) published an in vivo examination of 
normal-appearing WM microstructural integrity in individu-
als with MCI and mild AD using the whole brain approach 
for the ﬁ  rst time, avoiding the biases of the a priori selection 
of ROIs. In this study, signiﬁ  cant regional decreases in FA 
were found in the WM of the two patient groups, as opposed 
to age-matched healthy controls, in voxel-by-voxel compari-
sons. Interestingly, the anatomical pattern of FA changes 
was similar for both patient groups with greater posterior 
than anterior involvement. In a complementary experiment Neuropsychiatric Disease and Treatment 2008:4(4) 739
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(Medina et al 2005), the same methodology was used to 
detect signiﬁ  cant voxel-wise FA reductions in a group of 
old normal controls (ONC) versus young normal controls 
(YNC). When these results were compared with the ﬁ  ndings 
of the ﬁ  rst experiment, the anterior/posterior distribution of 
voxel-wise anisotropy reductions was signiﬁ  cantly different 
between the ONC vs YNC comparisons and the MCI and AD 
vs ONC comparisons, with a greater percentage of posterior 
WM integrity loss in the cognitively affected patients. These 
results further contribute to the body of evidence in favor of 
a more pronounced posterior WM damage in cognitively 
impaired elderly individuals.
What is DTI telling us?
The DTI-detected regional WM alterations in AD seem to 
parallel the pattern of changes followed by the GM in the 
disease process, that is, cortical abnormalities are greater 
in posterior brain regions relative to anterior regions at the 
early stages of AD (Arnold et al 1991; Braak and Braak 
1995). As the disease advances, the neuroﬁ  brillary pathology 
progresses from limbic to frontal structures, into high-order 
association cortices, and ﬁ  nally affects primary sensorimo-
tor areas, which correlates with the clinical manifestations 
of AD. From post-mortem specimens to different imaging 
modalities, eg, MRI, PET, and SPECT, this typical sequence 
has been conﬁ  rmed at different points of the disease (for a 
review, see Thompson et al 2007).
Fibers located deep in the posterior WM, such as the 
superior longitudinal fasciculus and the posterior cingu-
lum bundle, are being consistently found to be affected 
in patients with AD and MCI, not only in ROI studies, 
but also in DTI-based tractography (Fellgiebel et al 2005; 
Xie et al 2005) and whole-brain DTI studies (Medina et al 
2006; Rose et al 2006; Zhang et al 2007). A strong body of 
evidence has supported the early involvement of the pos-
terior cingulate (PC) in the progression of AD. Histologic, 
volumetric (Callen et al 2001), and metabolic (Reiman et al 
1996, 2001; Minoshima et al 1997; Valla et al 2001) data 
have shown that the PC is not only involved early in AD, 
but it may also undergo changes even in asymptomatic 
genetically predisposed individuals (Reiman et al 2001). A 
plausible explanation for these phenomena has been proposed 
by Bartzokis (Bartzokis 2004; Bartzokis et al 2003, 2004). 
According to this model, as the brain development takes 
place, later myelinated regions (cortical association areas) 
have fewer oligodendrocytes supporting greater numbers of 
axons compared with earlier myelinated regions (primary 
sensorimotor regions). Oligodendrocytes in the cortical 
association areas have higher metabolic demands in order 
to maintain the widely distributed axons, making them more 
susceptible to pathological processes such as oxidative stress 
and accumulation of ferritin iron. These and other metabolic 
insults may lead to decreased WM integrity in association 
cortical regions. In general, the DTI ﬁ  ndings of decreased 
WM integrity in later-myelinated regions at the onset of AD 
support this “reversed de-myelination” construct.
Cerebrovascular disease and WM dysfunction are inher-
ently associated with vascular risk factors such as diabetes, 
myocardial infarction or hypertension. In addition to isch-
emic events, common in the elderly population, those factors 
seem to be also related to an increased risk of AD (Kalaria 
2000, 2002; Urresta et al 2003). Thus, vascular pathology 
may be an additive element to the deleterious effects of aging 
in more vulnerable, long cortico-cortical WM tracts.
DTI has been successfully applied to the study of dis-
eases causing axonal damage (Ulug et al 1999), identifying 
reductions in anisotropy not only in macroscopic WM lesions 
but also at the microscopic level (Stieltjes et al 2001). The 
DTI renditions of changes in cerebral diffusion occurring 
in the WM of stroke patients have made possible the dis-
crimination in vivo between primary (direct) and secondary 
(Wallerian) degeneration (Makris et al 1997; Mukherjee et al 
2000; Werring et al 2000; Pierpaoli et al 2001). In the case of 
direct damage to the WM, as liquefactive necrosis takes place 
and the content of isotropic free water, ie cerebrospinal ﬂ  uid, 
increases in the axon, severe reductions in FA are accompa-
nied by an increase in mean diffusivity – otherwise known as 
trace D – as a result of a global increase in diffusivity in all 
directions. On the other hand, although Wallerian degenera-
tion is also characterized by reduced FA and, albeit lesser, 
increases in mean diffusivity, there are differential changes 
in directional diffusivities: axial diffusivity (DA: diffusion 
parallel to the main axis of the tract) is reduced while radial 
diffusivity (DR: diffusion perpendicular to the main axis of 
the tract) remains high.
As mentioned in the previous section, there is plenty 
of pathoanatomical evidence of WMC in AD, thought to 
be the result of a constellation of pathologies such as WM 
rarefaction and axonal gliosis, probably related to ischemia, 
and an anterograde Wallerian degeneration that may follow 
the stereotypic pattern of AD cortical atrophy. Consequently, 
DTI directional diffusivities have been used to elucidate the 
extent of Wallerian degeneration in the normal-appearing 
WM of MCI and mild AD patients (Huang and Auchus 
200; Huang et al 2007). The most consistent ﬁ  ndings of a 
pilot study using this approach (Huang et al 2007) were seen Neuropsychiatric Disease and Treatment 2008:4(4) 740
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in the temporal lobes: both MCI and AD groups showed 
signiﬁ  cant reductions in FA, but the MCI group showed only 
a decrease in DA – probably reﬂ  ecting an incipient axonal 
damage in a vulnerable target area – while the AD group 
showed decreases in DA and increases in DR, suggesting 
a more advance state of coexistent axonal destruction and 
demyelination that is coupled with the characteristic pattern 
of AD cortical loss.
DTI investigators are also looking for correlations 
between their regional estimations of WM integrity and 
cognitive function. Relationships have been sought between 
scores of a widely used diagnostic instrument in dementia 
studies, the Mini Mental State Examination (MMSE: Folstein 
et al 1975), and WM mean diffusivity and anisotropy values, 
with ﬁ  ndings of decreased cognitive status associated with 
decreased WM integrity in cerebral posterior regions of AD 
subjects (Rose et al 2000; Bozzali et al 2002; Yoshiura et al 
2002; Duan et al 2006). Further research including amnestic 
MCI populations and utilizing appropriate neuropsychologi-
cal tests of declarative memory, has demonstrated signiﬁ  cant 
correlations between declining performance in these tasks 
and decreases in posterior WM anisotropy, particularly in 
the posterior cingulum bundles (Fellgiebel et al 2005, 2007; 
Rose et al 2006). Moreover, Huang et al (2007, see above) 
were able to delineate a neuroanatomical pattern of functional 
alterations in their cognitively impaired elderly subjects in 
such a way that changes in WM diffusion indices of the 
temporal lobes correlated with scores of episodic memory, 
WM diffusion changes in the frontal lobes correlated with 
scores of executive function, and WM diffusion changes in 
parietal lobes correlated with scores of visuospatial skills. 
This pattern might be indicative of the vulnerability of 
cortical cognitive systems to the deterioration of the WM 
pathways embedded beneath the disease-targeted gyri, and 
postulates disruptions in transcortical connectivity as an early 
contributor to the pathophysiology of dementia.
What’s coming next?
In pursuit of a deeper understanding of WMC in AD, inves-
tigators are narrowing their scope into brain areas that are 
difﬁ  cult to access by conventional neuroimaging tools. The 
perforant path (PP), a parahippocampal WM bundle that 
originates from cells in the entorhinal cortex and provides 
the hippocampus with its major cortical input, has been 
elusive to the DTI community due to the technical con-
strains of the ROI approach, particularly in terms of partial 
volume effects. In an effort to surmount these difﬁ  culties, 
high resolution DTI protocols are being used in combination 
with high resolution anatomical MRI scans to obtain in vivo 
evidence of reductions in WM volume and FA in parahip-
pocampal regions of patients with AD (Wang et al 2006). A 
similar bimodal ROI approach had comparable ﬁ  ndings in 
a DTI study of the PP that included AD and MCI patients 
(Kalus et al 2006), and through the beneﬁ  t of an optimized 
voxel-based method, Rose and colleagues (2006) were able 
to replicate parahippocampal WM changes when they exam-
ined a group of MCI patients. Taken together, these results 
suggest that a disruption in the ﬂ  ow of information to the 
hippocampus may exist since the beginnings of AD, giving 
WM dysfunction a refreshed protagonic role in the study of 
age-associated cognitive impairment.
Promising applications such as DTI-based tractography 
(DTT) or voxel-wise analyses are not free of limitations 
either. Apart from partial voluming effects, ubiquitous arti-
facts arise when a tract of interest is reconstructed through 
DTT, due to a problematic reproduction of the natural 
angulations of WM ﬁ  bers. A recent advance in this topic is 
a provocative proposal by Yasmin et al (2008), in which a 
minimally operator-dependent optimized DTT technique, the 
“erosion” method, was used to detect neatly decreases in FA 
in the uncinate fasciculum of AD subjects. Problems in voxel-
wise studies are related to the coregistration of individual 
DTI maps to standard templates and their segmentation via 
probability masks. Deﬁ  ning the proper criteria for smoothing 
and thresholding of the images for statistical purposes are 
additional issues. Laudable initiatives towards a careful align-
ment of DTI images and the use of sample-speciﬁ  c averages 
instead of exogenous templates have replicated the previously 
reported WM anisotropy changes occurring in posterior WM 
regions of AD subjects (Rose et al 2008).
A new technical development called tract-based spatial 
statistics (TBSS: Smith et al 2006), which aimed to com-
bine the strengths and to compensate for the weaknesses 
among the aforementioned methods, is being included in 
some of the commonly used open-source software tools 
for post-processing of DTI data. Instead of calculating the 
FA of a speciﬁ  c tract of interest, TBSS creates a “mean FA 
skeleton” from the very sample under investigation and later 
projects individual FA maps to this unique “skeleton-space”, 
avoiding alignment and smoothing issues and permitting 
voxel-wise statistical comparisons among groups. Although 
yet to be seen in AD, this kind of solution will surely help to 
provide more precise information about the WM compromise 
in the malfunction of the aging brain.
Current multi-center collaborative initiatives such 
a the National Alliance for Medical Imaging Computer Neuropsychiatric Disease and Treatment 2008:4(4) 741
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(www.na-mic.org) or the Biomedical Informatic Research 
Network (www.nbirn.net) are trying to develop automated 
image calibration and analysis tools to facilitate the gathering 
of larger amounts of DTI data (among other imaging modali-
ties), and to make that information available to the research 
community in public databases. These projects are seeking 
to enhance the applicability of the technique, ie, to develop 
biomarkers suitable for the monitoring of therapeutic efﬁ  cacy 
in clinical trials, or to identify patients at risk and susceptible 
to beneﬁ  t from early pharmacological interventions.
References
Arnold SE, Hyman BT, Flory J, et al. 1991. The topographical and neuro-
anatomical distribution of neuroﬁ  brillary tangles and neuritic plaques 
in the cerebral cortex of patients with Alzheimer’s disease. Cerebral 
Cortex, 1:103–16.
Bartzokis G. 2004. Age-related myelin breakdown: a developmental 
model of cognitive decline and Alzheimer’s disease. Neurobiol Aging, 
25:5–18.
Bartzokis G, Cummings JL, Sultzer D, et al. 2003. White matter structural 
integrity in healthy aging adults and patients with Alzheimer’s disease. 
Arch Neurol, 60:393–8.
Bartzokis G, Sultzer D, Lu PH, et al. 2004. Heterogenous age related 
breakdown of white matter structural integrity: implications for cortical 
“disconnection” in aging and Alzheimer’s disease. Neurobiol Aging, 
25:843–51.
Basser PJ. 1995. Inferring microstructural features and the physiologi-
cal state of tissues from diffusion-weighted images. NMR Biomed, 
8:333–44.
Basser PJ, Mattiello J, LeBihan D. 1994a. MR diffusion tensor spectroscopy 
and imaging. Biophys J, 66:259–67.
Basser PJ, Matiello J, Le Bihan D. 1994b. Estimation of the effective 
self-diffusion tensor from the NMR spin echo. J Magn Reson B, 103: 
247–54.
Basser PJ, Pierpaoli C. 1996. Microstructural and physiological features 
of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn 
Reson B, 111:209–19.
Beaulieu C. 2002. The basis of anisotropic water diffusion in the nervous 
system – a technical review. NMR Biomed, 15:435–55.
Bobinski M, de Leon MJ, Convit A, et al. 1999. MRI of entorhinal cortex 
in mild Alzheimer’s disease. Lancet, 353:38–40.
Bozzali M, Falini A, Franceschi M, et al. 2002. White matter damage in 
Alzheimer’s disease assessed in vivo using diffusion tensor magnetic 
tensor imaging. J Neurol Neurosurg Psychiatry, 72:742–6.
Bozzao A, Floris R, Baviera ME, et al. 2001. Diffusion and perfusion MR 
imaging in cases of Alzheimer’s disease: correlations with cortical 
atrophy and lesion load. AJNR Am J Neuroradiol, 22:1030–6.
Braak H, Braak E. 1995. Staging of Alzheimer’s disease-related neuroﬁ  bril-
lary changes. Neurobiol Aging, 16:271–8.
Bronge L, Bogdanovic N, Wahlund LO. 2002. Postmortem MRI and 
histopathology of white matter changes in Alzheimer brains. Dement 
Geriatr Cogn Disord, 13:205–12.
Brun A, Englund E. 1986. A white matter disorder in dementia of the 
Alzheimer type: a pathoanatomical study. Ann Neurol, 19:253–62.
Callen DJA, Black SE, Gao F, et al. .2001. Beyond the hippocampus: MRI 
volumetry conﬁ  rms widespread limbic atrophy in AD. Neurology, 
57:1669–74.
Conturo TE, Lori NF, Cull TS, et al. 1999. Tracking neuronal ﬁ  ber pathways 
in the living human brain. Proc Natl Acad Sci USA, 96:10422–7.
Convit A, de Leon MJ, Tarshish C, et al. 1997. Speciﬁ  c hippocampal volume 
reductions in individuals at risk for Alzheimer’s disease. Neurobiol 
Aging, 18:131–18.
deToledo-Morrell L, Goncharova I, Dickerson B, et al. 2000. From healthy 
aging to early Alzheimer’s disease. In vivo detection of entorhinal cortex 
atrophy. Ann NY Acad Sci, 911:240–53.
deToledo-Morrell L, Stoub TR, Bulgakova M, et al. 2004. MRI-derived 
entorhinal volume is a good predictor of conversion from MCI to AD. 
Neurobiol Aging, 25:1197–203.
deToledo-Morrell L, Sullivan MP, Morrell F, et al. 1997. Alzheimer’s 
disease: In vivo detection of differential vulnerability of brain regions. 
Neurobiol Aging, 18:463–8.
Dickerson BC, Goncharova I, Sullivan MP, et al. 2001. MRI-derived ento-
rhinal and hippocampal atrophy in incipient and very mild Alzheimer’s 
disease. Neurobiol Aging, 22:747–54.
Du AT, Schuff N, Amend D, et al. 2001. Magnetic resonance imaging of the 
entorhinal cortex and hippocampus in mild cognitive impairment and 
Alzheimer’s disease. J Neurol Neurosurg Psychiatry, 71:441–7.
Duan JH, Wang HQ, Xu J, et al. 2006. White matter damage of patients with 
Alzheimer's disease correlated with the decreased cognitive function. 
Surg Radiol Anat, 28:150–6.
Englund E. 1998. Neuropathology of white matter changes in Alzheimer’s 
disease and vascular dementia. Dement Geriatr Cogn Disord, 
9 (Suppl 1):6–12.
Fellgiebel A, Müller MJ, Wille P, et al. 2005. Color-coded diffusion-tensor-
imaging of posterior cingulate ﬁ  ber tracts in mild cognitive impairment. 
Neurobiol Aging, 26:1193–8.
Fellgiebel A, Schermuly I, Gerhard A, et al. 2007. Functional relevant loss 
of long association ﬁ  bre tracts integrity in early Alzheimer’s disease. 
Neuropsychologia. [Dec 23 Epub ahead of print].
Fellgiebel A, Wille P, Müller MJ, et al. 2004. Ultrastructural hippocampal 
and white matter alterations in Mild Cognitive Impairment: a diffusion 
tensor imaging study. Dement Geriatr Cogn Disord, 18:101–8.
Folstein MF, Folstein SE, McHugh PR. 1975. Mini-Mental State. A Practi-
cal method for grading the mental status of patients for the clinician. 
J Psychiatric Res, 12:189–92.
Hanyu H, Asano T, Sakurai H, et al. 1999. Diffusion-weighted and magne-
tization transfer imaging of the corpus callosum in Alzheimer’s disease. 
J Neurol Sci, 167:37–44.
Hanyu H, Sakurai H, Iwamoto T, et al. 1998 Diffusion-weigthed MR 
imaging of the hippocampus and temporal white matter in Alzheimer’s 
Disease. J Neurol Sci, 156:195–200.
Head D, Buckner RL, Shimony JS, et al. 2004. Differential vulnerability of 
anterior white matter in nondemented aging with minimal acceleration 
in dementia of the Alzheimer type: Evidence from diffusion tensor 
imaging. Cereb Cortex, 14:410–23.
Higano S, Zhong J, Shrier DA, et al. 2001. Diffusion anisotropy of the 
internal capsule and the corona radiata in association with stroke and 
tumors as measured by diffusion-weighted MR imaging. AJNR Am J 
Neuroradiol, 22:456–63.
Hossmann KA, Hoehn-Berlage M. 1995. Diffusion and perfusion MR imag-
ing of cerebral isquemia. Cerebrovasc Brain Metab Rev, 7:187–217.
Huang J, Auchus AP. 2007. Diffusion tensor imaging of normal appearing 
white matter and its correlation with cognitive functioning in mild 
cognitive impairment and Alzheimer’s disease. Ann NY Acad Sci, 
1097:259–64.
Huang J, Friedland RP, Auchus AP. 2007. Diffusion tensor imaging of 
normal-appearing white matter in mild cognitive impairment and early 
Alzheimer disease: preliminary evidence of axonal degeneration in the 
temporal lobe. AJNR Am J Neuroradiol, 28:1943–8.
Jack CR, Petersen RC, O’Brien PC, et al. 1992. MR-based hippocam-
pal volumetry in the diagnosis of Alzheimer’s disease. Neurology, 
42:183–8.
Jack CR, Petersen RC, Xu YC, et al. 1997. Medial temporal atrophy on 
MRI in normal aging and very mild Alzheimer’s disease. Neurology, 
49:786–94.
Kalaria RN. 2000. The role of cerebral ischemia in Alzheimer’s disease. 
Neurobiol Aging, 21:321–30.
Kalaria RN. 2002. Small vessel disease and Alzheimer’s dementia: Patho-
logical considerations. Cerebrovasc Dis, 13 (Suppl 2):48–52.Neuropsychiatric Disease and Treatment 2008:4(4) 742
Medina and Gaviria
Kalus P, Slotboom J, Gallinat J, et al. 2006. Examining the gateway to the 
limbic system with diffusion tensor imaging: the perforant pathway in 
dementia. Neuroimage, 30:713–20.
Kantarci K, Jack CR, Xu YC, et al. 2001. Mild cognitive impairment 
and Alzheimer’s disease: Regional diffusivity of water. Radiology, 
219:101–7.
Killiany RJ, Gomez-Isla T, Moss M, et al. 2000. Use of structural magnetic 
resonance imaging to predict who will get Alzheimer’s disease. Ann 
Neurol, 47:430–9.
Killiany RJ, Hyman BT, Gomez-Isla T, et al. 2002. MRI measures of 
entorhinal cortex vs hippocampus in preclinical AD. Neurology, 
58:1188–96.
Lansberg MG, Albers GW, Beaulieu C, et al. 2000. Comparison of diffusion-
weighted MRI and CT in acute stroke. Neurology, 54:1557–61.
Lansberg MG, O’Brien MW, Tong DC, et al. 2001. Evolution of cerebral 
infarct volume assessed by diffusion-weighted magnetic resonance 
imaging. Arch Neurol, 58: 613–7.
Le Bihan D, Mangin JF, Poupon et al. 2001. Diffusion tensor imaging: 
concepts and applications. J Magn Reson Imaging, 13:534–46.
Lutsep HL, Albers GW, DeCrespigny A, et al. 1997. Clinical utility of 
diffusion-weighted magnetic resonance imaging in the assessment of 
ischemic stroke. Ann Neurol, 41:574–80.
Medina DA, Stebbins GT, deToledo-Morrell L, et al. 2005. DTI detects 
dissociated patterns on regional distribution of white matter changes 
in the elderly. Program No. 542.13. 2005 Abstract Viewer/Itinerary 
Planner. Washington, DC: Society for Neuroscience [online].
Medina D, deToledo-Morrell L, Urresta F, et al. 2006. White matter changes 
in mild coginitve impairment and AD: a difusion tensor imaging study. 
Neurobiol Aging, 27:663–72.
Minoshima S, Giordani B, Berent S, et al. 1997. Metabolic reduction in 
the posterior cingulate cortex in very early Alzheimer’s disease. Ann 
Neurol, 42:85–94.
Makris N, Worth AJ, Sorenson AG, et al. 1997. Morphometry of in vivo 
human white matter association pathways with diffusion-weighted 
magnetic resonance imaging. Ann Neurol, 42:951–62.
Moseley ME, Cohen Y, Mintorovitch J, et al. 1990. Early detection of 
regional cerebral ischemia in cats: comparison of diffusion- and 
T2-weighted MRI and spectroscopy. Magn Reson Med, 14: 330–46.
Mukherjee P, Bahn MM, McKinstry RC, et al. 2000. Differences between 
gray matter and white matter diffusion in stroke: Diffusion-tensor MR 
imaging in 12 patients. Neuroradiology, 215:211–20.
Naggara O, Oppenheim C, Rieu D, et al. 2006. Diffusion tensor imaging in 
early Alzheimer’s disease. Psychiatry Res, 146:243–9.
Neumann-Haefelin T, Moseley ME, Albers GW. 2000. New magnetic 
resonance imaging methods for cerebrovasclular disease: emerging 
clinical applications. Ann Neurol, 47: 559–70.
Pajevic S, Pierpaoli C. 1999. Color schemes to represent the orientation 
of anisotropic tissues from diffusion tensor data: application to white 
matter ﬁ  ber tract mapping in the human brain [erratum in Magn Reson 
Med, 2000 43(6):921]. Magn Reson Med, 42:526–40.
Petersen RC, Doody R, Kurz A, et al. 2001. Current concepts in mild cogni-
tive impairment. Arch Neurol, 58:1985–92.
Pierpaoli C, Barnett A, Pajevic S, et al. 2001. Water diffusion changes in 
wallerian degeneration and their dependence on white matter architec-
ture. Neuroimage, 13:1174–85.
Poupon C, Clark CA, Frouin V, et al. 2000. Regularization of diffusion-
based direction maps for the tracking of brain white matter fascicles. 
Neuroimage, 12: 184–95.
Reiman EM, Caselli RJ, Chen K, et al. 2001. Declining brain activity in 
cognitively normal apolipoprotein E ε4 heterozygotes: A foundation 
for using positron emission tomography to efﬁ  ciently test treatments to 
prevent Alzheimer’s disease. Proc Natl Acad Sci USA, 98:334–9.
Reiman EM, Caselli RJ, Yun LS, et al. 1996. Preclinical evidence of 
Alzheimer’s disease in persons homozygous for the epsilon 4 allele 
for apolipoprotein E. N Engl J Med, 334:752–8.
Rose SE, Chen F, Chalk JB, et al. 2000. Loss of connectivity in Alzheimer’s 
disease: an evaluation of white matter tract integrity with color 
coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry, 
69:528–30.
Rose SE, Janke AL, Chalk JB. 2008. Gray and white matter changes in 
Alzheimer’s disease: a diffusion tensor imaging study. J Magn Reson 
Imaging, 27:20–6.
Rose SE, McMahon KL, Janke AL, et al. 2006. MRI diffusion indices 
and neuropsychological performance in amnestic mild cognitive 
impairment. J Neurol Neurosurg Psychatry, 77: 1122–8.
Sandson TA, Felician O, Edelman RR, et al. 1999. Diffusion-weighted 
magnetic resonance imaging in Alzheimer’s disease. Dement Geriatr 
Cogn Disord, 10: 166–71.
Smith SM, Jenkinson M, Johansen-Berg H, et al. 2006. Tract-based 
spatial statistics: voxelwise analysis of multi-subject diffusion data. 
Neuroimage, 31:1487–505.
Stieltjes B, Kaufmann WE, van Zijl PC, et al. 2001. Diffusion tensor 
imaging and axonal tracking in the human brainstem. Neuroimage, 
14:723–35.
Sydykova D, Stahl R, Dietrich O, et al. 2007. Fiber connections between 
the cerebral cortex and the corpus callosum in Alzheimer’s disease: a 
diffusion tensor imaging and voxel-based morphometry study. Cereb 
Cortex, 17:2276–82.
Takahashi S, Yonezawa H, Takahashi J, et al. 2002. Selective reduction 
of diffusion anisotropy in white matter of Alzheimer’s disease brains 
measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett, 
332:45–8.
Thompson PM, Hayashi KM, Dutton RA, et al. 2007. Tracking Alzheimer’s 
disease. Ann NY Acad Sci, 1097: 183–214.
Ulug A, Moore DF, Bojko AS, et al. 1999. Clinical use of diffusion-tensor 
imaging for diseases causing neuronal and axonal damage. AJNR Am 
J Neuroradiol, 20:1044–8.
Urresta F, Medina DA, Gaviria M. 2003. Diffusion MRI studies in vascular 
cognitive impairment and dementia. Rev Bras Psichiatr, 25:188–91.
Valla J, Berndt JD, Gonzalez-Lima F. 2001. Energy hypometabolism in 
posterior cingulate cortex of Alzheimer’s patients: superﬁ  cial laminar 
cytochrome oxidase associated with disease duration. J Neurosci, 
13:4923–30.
Virta A, Barnett A, Pierpaoli C. 1999. Visualizing and characterizing white 
matter ﬁ  ber structure and architecture in the human pyramidal tract 
using diffusion MRI. Mag Reson Imaging, 17:1121–33.
Wang C, Medina D, Stebbins G, et al. 2006. Changes in the microstruc-
tural integrity of parahippocampal white-matter tracts in Alzheimer’s 
disease. 2006 Neuroscience Meeting Planner. Atlanta, GA: Society for 
Neuroscience [online].
Werring DJ, Toosy AT, Clark CA, et al. 2000. Diffusion tensor imaging 
can detect and quantify corticospinal tract degeneration after stroke. 
J Neurol Neurosurg Psychiatry, 69:269–72.
Xu Y, Jack CR, O’Brien PC, et al. 2000. Usefulness of MRI measures of 
entorhinal cortex versus hippocampus in AD. Neurology, 54:1760–7.
Yasmin H, Nakata Y, Aoki S, et al. 2008. Diffusion abnormalities of the 
uncinate fasciculus in Alzheimer’s disease: diffusion tensor tract-
speciﬁ  c analysis using a new method to measure the core of the tract. 
Neuroradiology, 504:293–9.
Yoneda Y, Tokui K, Hanihara T, et al. 1999. Diffusion-weighted magnetic 
resonance imaging: detection of isquemic injury 39 minutes after onset 
in a stroke patient. Ann Neurol, 45:794–7.
Yoshiura T, Mihara F, Ogomori K, et al. 2002. Diffusion tensor in posterior 
cingulate gyrus: correlation with cognitive decline in Alzheimer’s 
disease. Neuroreport, 13:2299–302.
Zhang Y, Schuff N, Jahng GH, et al. 2007. Diffusion tensor imaging of 
cingulum ﬁ  bers in mild cognitive impairment and Alzheimer disease. 
Neurology, 68:13–19.